Nautilus Biotechnology Stock

www.nautilus.bioHealthcareFounded: 2021

Nautilus is a biotechnology company who is developing a proteomics platform enabling a dramatic acceleration of basic science research, significantly improving the success rate of therapeutic development, and enhancing opportunities for personalized and predictive medicine.

Register for Details

For more details on financing and valuation for Nautilus Biotechnology, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Nautilus Biotechnology.

Register Today

Other companies like Nautilus Biotechnology in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B